In today’s recent session, 0.69 million shares of the Ventyx Biosciences Inc (NASDAQ:VTYX) have been traded, and its beta is 0.50. Most recently the company’s share price was $2.24, and it changed around -$0.14 or -5.67% from the last close, which brings the market valuation of the company to $162.15M. VTYX at last check was trading at a discount to its 52-week high of $11.48, offering almost -412.5% off that amount. The share price’s 52-week low was $1.67, which indicates that the recent value has risen by an impressive 25.45% since then. We note from Ventyx Biosciences Inc’s average daily trading volume that its 10-day average is 1.74 million shares, with the 3-month average coming to 1.41 million.
Ventyx Biosciences Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.67. If we narrow it down even further, the data shows that 0 out of 9 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 3 recommended VTYX as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight.
Ventyx Biosciences Inc (NASDAQ:VTYX) trade information
Instantly VTYX has been showing red trend so far today with a performance of -5.67% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.50 on recent trading dayincreased the stock’s daily price by 10.4%. The company’s shares are currently down -9.11% year-to-date, but still up 0.22% over the last five days. On the other hand, Ventyx Biosciences Inc (NASDAQ:VTYX) is -15.28% down in the 30-day period. We can see from the shorts that 8.63 million shares have been sold at a short interest cover period of 4.15 day(s).
The consensus price target as assigned by Wall Street analysts is $45, which translates to bulls needing to increase their stock price by 95.02% from its current value. Analyst projections state that VTYX is forecast to be at a low of $6 and a high of $60.
Ventyx Biosciences Inc (VTYX) estimates and forecasts
Ventyx Biosciences Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -0.66 percent over the past six months and at a 36.67% annual growth rate that is well above the industry average of 16.70%. Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -148.81%.
Ventyx Biosciences Inc (NASDAQ:VTYX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 4.49% of Ventyx Biosciences Inc shares, and 84.90% of them are in the hands of institutional investors. The stock currently has a share float of 88.89%. Ventyx Biosciences Inc stock is held by 168.0 institutions, with DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) being the largest institutional investor. By 2024-06-30, it held 9.4284% of the shares, which is about 5.83 million shares worth $13.47 million.
CITADEL ADVISORS LLC, with 9.3133% or 5.76 million shares worth $13.3 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
